Delivery Order SPE2DB20D7059-SPE2DB25FGTH8
- Not listed
- The Defense Logistics Agency awarded a $4,349.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Isosorbide Mononitrate 20 mg tablets (100 count) with a completion date of July 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support federal medical supply needs, likely for military or veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Isosorbide Mononitrate 20 mg tablets (100-count bottles) under a firm fixed-price contract valued at $2,135.88. This non-competitive set-aside delivery order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete purchase order issued under a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.92, is for the delivery of 4,568,171,219 units of Isosorbide Mononitrate 20 mg tablets in 100-count packages. The contract is a firm-fixed-price, non-set-aside award with a performance period ending on May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $14,690.80 delivery order to AmerisourceBergen Drug Corp for the supply of Isosorbide Dinitrate 40 mg tablets (100-count units) with a firm fixed price contract structure. This non-set-aside award, effective September 16, 2025, with an ultimate completion date of September 17, 2025, supports federal pharmaceutical procurement needs with performance to occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a...
- This federal contract award, valued at $47,793.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers the...
- This federal contract award, valued at $3,479.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,722,938 units of Isosorbide Dinitrate 40 mg tablets, a drug used for the treatment of cardiovascular conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,193.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Isoniazid 300 mg tablets in quantities of 30. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,177.32 delivery order from the Defense Logistics Agency on September 9, 2025, for 1,000 tablets of Nitrofurantoin Mono-MCR 100 mg. The award, designated as contract number 4569419187, is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the vendor's corporate office location in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,197.46 firm fixed-price delivery order is for the supply of 4566791051 NTG 0.2 MG/ML IN D5W 250 ML, with a completion date of December 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a $1,337.76 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-320-25 MG in a 30-count package. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by September 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGTH8Delivery Order
The Defense Logistics Agency awarded a $1,067.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Isosorbide Mononitrate 20 mg, a cardiovascular medication used to treat angina. The contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This award represents a delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. The DLA's Pharmaceutical Prime Vendor Global Program represents a critical supply chain mechanism for ensuring the availability of essential medications across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/25/25 |